Abstract
AIM:
Aim of this study was to examine the effectiveness of body acupuncture on body weight loss, routine laboratory tests and pro-inflammatory markers.
METHODOLOGY:
The study was performed on eighty obese patients. They were divided into three groups according to their body mass index. Subjects received acupuncture for three- six months in combination with a low-calorie diet. They were assessed pre and post acupuncture, by anthropometric measurement, routine laboratory tests and, tumor necrosis factor- alpha (TNF-α), interleukin- 6 (IL-6), and high sensitivity C-reactive protein (hsCRP) levels in serum.
RESULTS:
The pre-acupuncture results showed significant difference between the three grades of obesity and the controls regarding TNFα, IL-6 and hsCRP. We found significant reduction in anthropometric measurement of adiposity after acupuncture. In comparing the pre &post acupuncture results of TNF-α, IL-6 and hsCRP showed high significant reduction after acupuncture. There are highly significant decrease in kidney function (creatinine and uric acid) and lipid profile (cholesterol and triglycerides) and fasting blood glucose, but there was no significant difference in urea, SGPT, SGOT, HDL and LDL.
CONCLUSION:
Body acupuncture in combination with diet restriction was found to be effective for weight loss and also reduction of the inflammatory reactions. Acupuncture could be used as a synergistic treatment option for obesity control.
Keywords: Acupuncture, Obesity, IL6, TNF, hsCRP
Introduction
Obesity is a chronic non-communicable disease with clinical and public health challenges [1]. Studies on human and animal models indicated that adipocytes secrete many inflammatory cytokines, and hence the excess of fat in obesity leads to a systemic chronic inflammation [2]. It is now admitted that the majority of inflammatory peptides is secreted by adipose tissue-resident macrophages [3].
Tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL6) are the most important cytokines responsible for the chronic inflammatory process [4]. In adults, their serum concentrations have been reported to correlate positively with measures of adiposity and to associate with the metabolic syndrome, cardiovascular disease, insulin resistance, and diabetes [2].
High sensitivity C-reactive protein (hsCRP) is a very sensitive marker of inflammation, which is synthesized in the liver, and this process is regulated predominately by IL-6 [4]. hsCRP is positively correlated with abdominal fat and closely correlated with increased risk of cardiovascular events [5].
Acupuncture originated in China more than 2,000 years ago, and is one of the oldest medical procedures in the world. Acupuncture involves the insertion of very fine, sterile needles at specific body points or “energy pathways.” The inserted needles act to stimulate the release of endorphins, the body’s natural “feel good” hormones. This can create a calming, relaxing effect, which counteracts the need for excessive eating brought about by increased stress, frustration or anxiety. In this respect, acupuncture can calm those so afflicted and help them lose weight without resorting to drugs [6].
Recent research has examined some of the mechanisms underpinning acupuncture’s anti-inflammatory effects which include mediation by sympathetic and parasympathetic pathways. Other reported anti-inflammatory effects of acupuncture include an antihistamine action and downregulation of proinflammatory cytokines such as TNF-α, IL-1β, IL-6, and IL-10 [7].
There are several studies which have evaluated the effect of acupuncture in the management of obesity [8, 9]. Acupuncture has been used in the treatment of several diseases including obesity and also immune-related diseases, such as allergic disorders, autoimmune diseases, and immunodeficiency [9]. However, most studies have methodological limitations, including small sample size and inadequately controlled study design [9].
To our knowledge, the effect of acupuncture during body weight loss has not been evaluated with respect to inflammatory and immunological markers such as TNF-α, IL-6 and hsCRP in Egyptian population. Thus, the aim of this study was to examine the effectiveness of body acupuncture on body weight loss, routine laboratory tests and pro-inflammatory markers (TNF-α, IL-6 and hsCRP).
Methods and Subjects
Study design
A randomized controlled clinical trial was performed on 80 obese patients entered in our project at National Research Centre. They were divided into 3 groups according to their body mass index (BMI). Subjects received acupuncture for 6 months in combination with a low-calorie diet.
In this study, overweight was defined as a body mass index (BMI) of 25 to < 30 and a BMI of ≥30 were defined as obesity. They neither had received any other weight control measures nor had any medical and/or drug history within the last 3 months before their participation in the study. Only classical Chinese body acupuncture and auricular acupuncture were allowed to be used. Those whom had diabetes, hypertension, heart disease, endocrine abnormalities, or pregnancy were excluded.
Participants were informed about the study both verbally and by written information sheets. Volunteers were given time to discuss the study and were encouraged to ask questions.
Controls were required to be placebo, no treatment, pharmacological or non pharmacological interventions (e.g. diet and exercise).
Anthropometric Measurements
For all patients, body weight (BW), BMI, and body fat mass were measured by body composition analyzer BC-418 (TANITA, Japan) according to a standard protocol. Height and body weight were measured with the subjects dressed in light clothing after an overnight fasting. The body weight of each subject was measured with a standard scale to an accuracy of ± 0.1 kg, and height was measured to an accuracy of ± 0.1 cm.
Acupuncture Treatment in Cases
Body points are: Hegu (LI4), Quchi (LI11), Liangmen (ST21), Tianshu (ST25), Zusanli (ST36), Fenglong (ST40), Neiting(ST44), Sanyinjiao(SP6), Daheng (SP15), Neiguan (PC6), Taichong (LR3), Guanyuan (CV4) and Zhongwan (CV12).
Acupuncture sessions was done twice weekly, each session was 30 minutes.
Auricular acupuncture: ear points are: Shenmen, Mouth, Stomach, Sanjiao, Liver, Spleen, Endocrine and Hunger points [10].
They are weekly applied to each ear alternatively.
Collection of Blood Samples
About 5 ml of venous blood samples were taken from each patient for analysis after a 12-hour fasting, 2 times during the study (at the beginning and 6 months later). Blood samples were collected into vacutainer tubes and centrifuged at 4000 rpm for 10 min. Hemolyzed samples were excluded from analysis. After separation, routine analysis was done and aliquots of serum were frozen at − 80°C for TNF-α, IL-6 and hsCRP analysis.
Routine Biochemical Analysis and Serum TNF-α, IL-6 and hsCRP analysis
Fasting blood glucose (FBG) was determined immediately on Olympus auto analyzer using hexokinase method. Serum GOT, GPT, urea, creatinine, uric acid (UA), cholesterol, triglycerides (TG) were determined using colorimetric methods on Olympus AU 400 supplied from Olympus Life and Material Science (Europe GmbH, Wendenstraße, Hamburg, Germany).
TNF-α was determined by ELISA [11] kit supplied from Anogen (2355 Derry Road East, Unit 23, Mississauga, Ontario, Canada). Il-6 was determined by ELISA [12] kit supplied from AviBion (Ani Biotech, tiilitie, Finland). Quantitative determination of hsCRP in serum is done by a micro plate immuoezymometric assay [13] supplied from Monobind Inc. (100 North Pointe drive, Lake Forest, USA).
Statistical analysis
Data was statistically described in terms of mean ± standard deviation (± SD), frequencies (number of cases) and percentages when appropriate. Comparison of numerical variables between the study groups was done using Mann Whitney U test for independent samples when comparing 2 groups and Kruskal Wallis test with Mann Whitney U test as post-hoc multiple 2-group comparisons when comparing more than 2 groups. For comparing pre and post acupunctures, Wilcoxon signed-rank test was used for continuous variables and McNemar test for two related dichotomous variables for detecting changes in responses due to intervention. P value less than 0.05 was considered statistically significant. All statistical calculations were done using computer programs SPSS (Statistical Package for the Social Science; SPSS Inc., Chicago, IL, USA) version 15 for Microsoft Windows.
Results
Table 1 shows that females represented 93.5% of the total 80 persons. Regarding BMI, obese patients were divided into three groups: obese I (BMI ranged 30 to 35) represented 27.5%, obese 2 (BMI ranged 35 to 40) represented 42.5% and obese 3 whose BMI was > 40 which and represented 30%. Steady pattern of weight gain was reported by about 40% of the studied population.
Table 1.
Characters | Total no= 80 |
---|---|
Sex: | |
Male | 6 (6.5) |
Female | 74 (93.5) |
BMI: (Kg/m2) | |
30-35 (group1) | 22 (27.5) |
35-40 (group2) | 34 (42,5) |
>40 (group3) | 24 (30.0) |
Wt. gain pattern: (%) | |
Steady | 32 (40,0) |
Sudden increase | 5 (6.3) |
Wt. gain after loss | 43 (53.7) |
There was a significant difference between the three groups of obesity and the controls regarding inflammatory mediators. Routine laboratory results showed that there were no significant differences between three groups of obesity and controls (Table 2).
Table 2.
Tests | Obese I n=22 | Obese 2 n=34 | Obese 3 n=24 | Controls n=23 | P value |
---|---|---|---|---|---|
Creatinine (mg/dL) | 0.7 ± 0.3 | 0.6 ± 0.4 | 0.6 ±0 .4 | 0.9 ±0 .3 | 0.486 |
Urea (mg/dL) | 33.2 ± 13.1 | 27.8 ± 13.2 | 24.5 ± 15.5 | 35.4 ± 15.6 | 0.407 |
SGOT (U/L) | 23.6 ± 13.0 | 22.6 ± 13.4 | 15.8 ± 12.6 | 23.7 ± 9.7 | 0.039 |
SGPT (U/L) | 21.6 ± 11.3 | 24.7 ± 17.0 | 15.5 ± 14.7 | 11.3 ± 6.2 | 0.072 |
Fasting blood glucose (mg/dL) | 100.9 ± 12.1 | 97.6 ± 34.7 | 81.0 ± 44.1 | 98.0 ± 20.7 | 0.226 |
Triglyceride (mg/dL) | 140.5 ± 51.5 | 125.4 ± 74.6 | 122.2 ± 87.0 | 135.6 ± 30.9 | 0.572 |
Cholesterol (mg/dL) | 210.7 ± 50.4 | 190.8 ± 71.3 | 176.2 ± 96.6 | 154.4 ± 1.7 | 0.885 |
Uric Acid (mg/dL) | 4.9 ± 1.3 | 5.8 ± 1.5 | 5.3 ± 1.2 | 4.4 ± 1.7 | 0.152 |
HDL (mg/dL) | 45.3 ± 13.5 | 44.9 ± 11.5 | 40.1 ± 14.4 | 50.4±6.9 | 0.654 |
LDL (mg/dL) | 116.7 ±58.1 | 118.8 ± 42.7 | 137.4 ± 34.4 | 68.6±28.2 | 0. 590 |
TNF-α (pg/ml) | 16.7 ± 4.7 | 16.6 ± 4.3 | 17.5 ± 5.9 | 11.2 ± 2.2 | 0.045 |
IL6 (pg/ml) | 16.8± 8.9 | 15.2 ± 7.1 | 15.6 ± 8.2 | 3.8 ± 2.1 | 0.000 |
hsCRP (μg/ml) | 20.5± 10.9 | 18.9 ± 11.9 | 22.5 ± 11.9 | 5.8 ± 3.9 | 0.024 |
Table 3 shows post-acupuncture results. there was no significant difference between three groups of obesity as regards routine lab analysis, except for HDL, FBG and SGPT that showed significant difference (P<0.05).
Table 3.
Tests | Obese I n=22 | Obese 2 n=34 | Obese 3 n=24 | P value |
---|---|---|---|---|
Creatinine (mg/dl) | 0.9 ± 0.2 | 0.8 ± 0.4 | 0.6 ± 0 .5 | 0.273 |
Urea (mg/dl) | 29.8 ± 14.6 | 31.1 ± 17.7 | 23.9 ± 19.6 | 0.355 |
SGOT (U/L) | 20.9 ± 11.3 | 19.7 ± 11.7 | 14.1 ± 10.7 | 0.398 |
SGPT (U/L) | 18.9 ± 10.0 | 19.9 ± 14.5 | 11.1 ± 10.2 | 0.032 |
Fasting blood glucose (mg/dL) | 93.0 ± 24.3 | 81.5 ± 33.6 | 58.5 ± 39.6 | 0.029 |
TG (mg/dL) | 117.9 ± 43.8 | 100.2 ± 62.7 | 90.9 ± 78.5 | 0.456 |
CHOL (mg/dL) | 195.0 ± 33.8 | 165.7 ± 69.6 | 131.8 ± 89.6 | 0.208 |
UA (mg/dL) | 4.0 ± 1.1 | 4.3 ± 2.0 | 3.2 ± 2.3 | 0.173 |
HDL (mg/dL) | 72.5 ± 57.1 | 54.4 ± 33.1 | 31.4 ± 25.2 | 0.010 |
LDL (mg/dL) | 110.1 ± 35.0 | 88.6 ± 59.6 | 62.9 ± 63.7 | 0.310 |
TNF -α (pg/ml) | 12.5 ± 2.8 | 12.6 ± 3.0 | 13.2 ± 3.8 | 0.934 |
IL6 (pg/ml) | 14.7 ± 9.3 | 10.9 ± 7.8 | 9.0 ± 9.6 | 0.111 |
hsCRP (μg/ml) | 15.4 ± 7.8 | 14.3 ± 8.3 | 18.2 ± 7.4 | 0.252 |
Table 4 shows mean level of routine laboratory analysis and inflammatory mediators pre and post acupuncture among obese. There is highly significant difference P<0.01 in kidney function (creatinine & U.A) and lipid profile (cholesterol &TG) and FBG, but no significant difference was found in Urea, SGPT, SGOT, HDL and LDL (P>0.05).
Table 4.
Variable | Pre acupuncture | Post acupuncture | P value |
---|---|---|---|
Weight (kg) | 96.9 ±15.1 | 91.6 ± 14.6 | 0.001 |
BMI (kg/m2) | 38.6 ± 5.3 | 36.6 ± 5.0 | 0.001 |
Body fat (%) | 44.6 ± 52 | 42.2 ± 5.4 | 0.001 |
Fat mass | 44.1 ± 11.2 | 39.6 ± 10.5 | 0.001 |
Visceral fat rating | 11.8 ± 3.7 | 10.5 ± 3.7 | 0.001 |
Basal metabolic rate | 6992.1 ± 926.7 | 6829.2 ± 836.4 | 0.001 |
Creatinin (mg/dL) | 0.6 ± 0.4 | 0.9 ± 1.0 | 0.001 |
Urea (mg/dL) | 26.6 ± 15.1 | 29.0 ± 17.5 | 0.255 |
GOT (U/L) | 19.8 ± 13.6 | 19.1 ± 11.5 | 0.451 |
GPT (U/L) | 19.9 ± 14.6 | 17.9 ± 13.1 | 0.723 |
Fasting blood glucose (mg/dL) | 91.8 ± 39.3 | 79.0 ± 35.2 | 0.001 |
HDL (mg/dL) | 33.8 ± 20.7 | 37.7 ± 21.4 | 0.058 |
LDL (mg/dL) | 99.7 ± 64.4 | 87.3 ± 56.9 | 0.165 |
TG (mg/dL) | 133.3 ± 80.3 | 103.9 ± 62.4 | 0.001 |
Cholesterol (mg/dL) | 186.8 ± 80.5 | 166.1 ± 70.4 | 0.001 |
UA (mg/dL) | 4.9 ± 2.4 | 4.0 ± 2.0 | 0.001 |
TNF-α (pg/ml) | 16.9 ± 4.7 | 12.4 ± 3.1 | 0.001 |
IL6 (pg/ml) | 14.2 ± 8.8 | 10.4 ± 8.6 | 0.001 |
hsCRP (μg/ml) | 21.3 ± 9.9 | 14.9 ± 7.7 | 0.001 |
TNF-α, IL6 and hsCRP showed high significant improvement after acupuncture by using non-parametricm (P<0.001).
Discussion
There are several studies which have evaluated the effect of acupuncture in the management of obesity [9, 14, 15]. Hsu et al., mentioned that waist circumference (WC) is related to the subcutaneous fat tissue of the abdomen, and higher effects of body acupuncture in impolitic activity and enhancing lipid metabolisms could be attributed to the direct effects of body acupuncture in redistribution, lyses of fat tissue and reducing waist circumferences [14]. In current study, different anthropometric measurements in cases showed highly significantly reduction after the acupuncture. A study was done by Hong also observed that acupuncture has the function of selectively reducing excrescent fat in certain parts of the body with extra fat accumulation without further advance after reaching the normal body weight [16]. However, there are some studies that have reported no significant effect of acupuncture in the treatment of obesity, but it should be noted that these studies were performed by auricular acupuncture therapy only [17, 18].
It is believed that acupuncture alters levels of central nervous system by stimulating peripheral nerves at acupoints. Signals are then carried by stimulated nerve resulting in changes in satiety and mood [6]. Acupuncture appears to be able to improve mood by increasing the release of neurotransmitters [19] and suppress appetite by the serotonin and endorphin-induced decreases in stress and depression [20, 21], whereas this effect was not seen by exercise and diet. In addition, it has been shown that application of electroacupuncture at Zusanli (ST-36) and Neiting (ST-44) of the rat caused the increase in the electrical activity of ventral-medical hypothalamus in the obese rat, leading to activation of the satiety center (22).
White adipose tissue (WAT) is a source of some proinflammatory cytokines such as TNF-α and IL-6, which may show both local and systemic effects [23, 24]. Xu et al., also reported that the increased expression of inflammation-specific genes by macrophages in the adipose tissue of obese mice [25].
Many studies showed correlation of TNF- α expression with increased body mass, WC [2, 4, 5]. Previous study on human subjects reported on the elevated levels of TNF-α in gingival crevicular fluid (GCF) of obese individuals. The authors reported on a 0.74αpg increase in GCF TNF-α with an increase of one BMI unit [26]. Moreover, Hotamisligil et al., have shown increased expression of the TNFR2 (TNF receptor 2) receptor in adipose tissue in patients with excessive body weight. They have also demonstrated that the level of the TNFR2 receptor in serum is six times higher in obese people than among their control group [27]. Similarly to TNF-α, serum IL-6 expression correlate with increased body mass, waist circumference, and free fatty acid levels [3, 28] with reduction in circulating IL-6 following weight loss [29]. IL-6 has been implicated as a marker for visceral adiposity because visceral adipose tissue releases more IL-6 than subcutaneous adipose tissue [30].
IL-6 can directly affect lipid metabolism and activate pathways to promote increased energy turnover. IL-6 stimulates lipolysis in humans, increases free fatty acid (FFA) concentrations and whole body fat oxidation adipokines [31]. Notably, IL-6 can decrease the expression and secretion of adiponectin in human adipocytes, as well as other markers of adipocyte differentiation [32]. These findings are in agreement with current study that showed that, in pre acupuncture treatment, there is a significant difference between three grades of obesity and controls regarding TNF-α, IL6. However, in interesting study by Stępie et al., they reported that BMI did not correlate with IL-6 and TNF-α in any investigated subgroups [4]. These findings are in agreement with results obtained by Agraval et al., who also did not observe any significant correlation between IL-6 and TNF-α with BMI in a North Indian healthy general population as well in both sexes [33]. In contrast, Stępie et al., observed a significant inverse correlation between waist to hip ratio (WHR) and TNF-α in the obese male group [4]. Based on the data obtained from this study it is difficult to explain this surprising relationship.
HsCRP is a feature of systemic inflammation and is positively associated with measures of adiposity such as BMI as demonstrated by large two cross-sectional studies [34, 35]. The study by Visser et al., included 8,678 women and demonstrated that obese subjects had CRP 6.21 times higher than those of normal weight [34]. Numerus studies found significant correlation between high level of hsCRP and measures of adiposity [3, 36, 37] and other studies reported reduction in hsCRP levels following weight loss [38, 39].
The effects of the immune system-related acupoints on inflammatory cytokines, such as TNF-α, IL-6 and hsCRP have not been researched sufficiently to date. Although several trials have investigated the influence of some acupoints on the various cytokine levels, there have been no adequately controlled studies comparing the effects of acupoints on the immune system [40]. In this study, we used four of the most common acupoints (Ren12, Li-11, St-36, and Sp-6) that used conventionally in infections and inflammatory diseases. We reported significant reduction of TNF-α and IL-6 after acupuncture. Yim and colleagues reported a decrease in increased serum TNF-α, IL-6, and IFN-γ levels as a result of 3 weekly sessions of electroacupuncture treatment, a total of 5–9 weeks on the St-36 point in collagen-induce arthritic mice. In this study, it was shown that acupuncture could provide a reduction in serum TNF-α level, which was already high in inflammatory arthritis [41]. Likewise, Tian et al., also found that serum TNF-α level increased in rats with ulcerative colitis compared to normal rats. After that, they performed electroacupuncture on the St-36 point once a day for 10 days on these rats [42]. As a result, they reported that there was a decrease in TNF-α level compared to the control rats. On the other hand, Jong and his team were unable to find any changes in IL-4, IL-6, IL-10, soluble interleukin-2 receptor, and IFN-γ levels in 9 healthy individuals in whom they had performed electroacupuncture on the Li-11 point [43]. Karatay et al., mentioned that TNF-α levels that were already expected to be within normal levels in healthy individuals were not affected by the acupuncture treatment in all acupuncture groups in which St-36 and Li-11 were also included [44]. Immediately after a single acupuncture treatment, Petti et al., also reported a significant decrease in IL-10, no significant change in IL-6, and an unexpected significant decrease in IL-2. Since the effects of a single acupuncture treatment are not likely to accurately predict the effects of a substantial course of acupuncture, it is difficult to interpret the results of this study [45].
This study showed significant reduction in hs-CRP level after weight reduction by acupuncture treatment. Many studies have found the same result as ours about the reduction in hsCRP levels following weight loss [4, 46]. Other studies by Hamid et al., found that changes in hs-CRP levels were not different between cases and control, implying this notion that hs-CRP changed independent of the effects of acupuncture [9]. In patients with rheumatologic problems that showed increase hsCRP serum level, some studies reported the inability of acupuncture to reduce hs-CRP levels [47, 48] and some other not [49].
At the end, some potential reasons for these discrepancies among different studies could be due to the differences in age, race, pubertal stage, obesity degree, and fat distribution.
In conclusion, obesity-associated risks factors reduction can be achieved by other modalities but due to lack of adverse events and continued effects after the therapy, acupuncture could be used as a proffered or synergic treatment option for obesity control.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
References
- 1.Pascal G, Ikwudinma A, Obiegbu N. Obesity and its cardio-metabolic co-morbidities among adult Nigerians in a primary care clinic of a tertiary hospital in South-Eastern, Nigeria. J Family Med Prim Care. 2013;2:20–26. doi: 10.4103/2249-4863.109936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Galcheva S, Iotova V, Yotov Y, Bernasconi S, Street M. Circulating proinflammatory peptides related to abdominal adiposity and cardiometabolic risk factors in healthy prepubertal children. Eur J Endocrinol. 2011;164:553–558. doi: 10.1530/EJE-10-1124. [DOI] [PubMed] [Google Scholar]
- 3.Makki K, Froguel P, Wolowczuk I. Adipose Tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm 2013; 139239. Mediators Inflamm. 2013:728987. doi: 10.1155/2013/139239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Stępień M, Stępień A, Wlazeł R, Paradowski M, Banach M, Rysz J. Obesity indices and inflammatory markers in obese non-diabetic normo- and hypertensive patients: a comparative pilot study. Lipids Health Dis. 2014;13:29. doi: 10.1186/1476-511X-13-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. International Journal of Endocrinology. 2013:11. doi: 10.1155/2013/678159. Article ID 678159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lacey JM, Tershakovec AM, Foster GD. Acupuncture for the treatment of obesity: a review of the evidence. International Journal of Obesity. 2003;27:419–427. doi: 10.1038/sj.ijo.0802254. [DOI] [PubMed] [Google Scholar]
- 7.McDonald J, Cripps A, Smith P, Smith C, Xue C, et al. The anti-inflammatory effects of acupuncture and their relevance to allergic rhinitis: A narrative review and proposed model. Evidence-Based Complementary and Alternative Medicine. 2013:12. doi: 10.1155/2013/591796. Article ID 591796. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Granath J, Ingvarsson S, von Thiele U, Lundberg U. Stress management: a randomized study of cognitive behavioral therapy and yoga. Cogn Behav Ther. 2006;35:3–10. doi: 10.1080/16506070500401292. [DOI] [PubMed] [Google Scholar]
- 9.Abdi H, Zhao B, Darbandi M, Mobarhan M, Tavallaie S, et al. The effects of body acupuncture on obesity: anthropometric parameters, lipid profile, and inflammatory and immunologic markers. The Scientific World Journal. 2012:11. doi: 10.1100/2012/603539. Article ID 603539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Li Y, Zheng H, Zheng Q, Zhao L, Qin E, et al. Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial. Trials. 2014;15:198. doi: 10.1186/1745-6215-15-198. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Huseynova G, Azizova G, Efendiyev A. Quantitative changes in serum IL-8, TNF-αand TGF-β1 levels depending on compensation stage in type 2 diabetic patients. Int J Diabetes & Metabolism. 2009;17:59–62. [Google Scholar]
- 12.Rasouli N, Kern P. Adipocytokines and the Metabolic Complications of Obesity. J Clin Endocrinol Metab. 2008;93:S64–S73. doi: 10.1210/jc.2008-1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Al-Hamdan AA, Al-Huthail RH, ALsaif MA, ALothman AM, Muammer MN, Al-orf SM, Saeeed AA, Mohamed BA. The Effect of Weight Reduction Diet on C-Reactive Protein Level in Obese-Adult Subjects. J Med Sci. 2009;9(1):17–23. [Google Scholar]
- 14.Hsu CH, Hwang KC, Chao CL, Chang HH, Chou P. Electroacupuncture in obese women: a randomized, controlled pilot study. Journal of Women’s Health. 2005;14:434–440. doi: 10.1089/jwh.2005.14.434. [DOI] [PubMed] [Google Scholar]
- 15.Lee MS, Hwan Kim J, Lim HJ, Shin BC. Effects of abdominal electroacupuncture on parameters related to obesity in obese women: a pilot study. Complementary Therapies in Clinical Practice. 2006;12:97–100. doi: 10.1016/j.ctcp.2006.01.002. [DOI] [PubMed] [Google Scholar]
- 16.Hong S. Relation between treatment course and theraputic effects of acupncture for female obesity of different types. Journal of Traditional Chinese Medicine. 2008;28940:258–261. doi: 10.1016/s0254-6272(09)60005-4. [DOI] [PubMed] [Google Scholar]
- 17.Mok MS, Parker LN, Voina S, Bray GA. Treatment of obesity by acupuncture. The American Journal of Clinical Nutrition. 1976;29:832–835. doi: 10.1093/ajcn/29.8.832. [DOI] [PubMed] [Google Scholar]
- 18.Allison DB, Kreibich K, Heshka S, Heymsfield SB. A randomised placebo-controlled clinical trial of an acupressure device for weight loss. International Journal of Obesity. 1995;19:653–658. [PubMed] [Google Scholar]
- 19.Han JS, Terenius L. Neurochemical basis of acupuncture analgesia. Annual Review of Pharmacology and Toxicology. 1982;22:193–220. doi: 10.1146/annurev.pa.22.040182.001205. [DOI] [PubMed] [Google Scholar]
- 20.Wenhe Z, Yucun S. Change in levels of monoamine neurotransmitters and their main metabolites of rat brain after electric acupuncture treatment. International Journal of Neuroscience. 1981;15:147–149. doi: 10.3109/00207458108985907. [DOI] [PubMed] [Google Scholar]
- 21.Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, et al. Endogenous opioids: biology and function. Annual Review of Neuroscience. 1984;7:223–255. doi: 10.1146/annurev.ne.07.030184.001255. [DOI] [PubMed] [Google Scholar]
- 22.Zhao M, Liu Z, Su J. The time-effect relationship of central action in acupuncture treatment for weight reduction. Journal of Traditional Chinese Medicine. 2000;20:26–29. [PubMed] [Google Scholar]
- 23.Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91. doi: 10.1126/science.7678183. [DOI] [PubMed] [Google Scholar]
- 24.Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995;95:2409–15. doi: 10.1172/JCI117936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30. doi: 10.1172/JCI19451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lundin M, Yucel-Lindberg T, Dahllöf G, Marcus C, Modéer T. Correlation between TNFαin gingival crevicular fluid and body mass index in obese subjects. Acta Odontologica Scandinavica. 2004;62:273–277. doi: 10.1080/00016350410000172. [DOI] [PubMed] [Google Scholar]
- 27.Hotamisligil GS, Arner P, Atkinson RL. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes. 1997;46:451–455. doi: 10.2337/diab.46.3.451. [DOI] [PubMed] [Google Scholar]
- 28.Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obesity Research. 2001;9:414–417. doi: 10.1038/oby.2001.54. [DOI] [PubMed] [Google Scholar]
- 29.Bastard J-P, Jardel C, Bruckert E, Blondy P, Capeau J, et al. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. Journal of Clinical Endocrinology and Metabolism. 2000;85:3338–3342. doi: 10.1210/jcem.85.9.6839. [DOI] [PubMed] [Google Scholar]
- 30.Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. Journal of Clinical Endocrinology and Metabolism. 1998;83:847–850. doi: 10.1210/jcem.83.3.4660. [DOI] [PubMed] [Google Scholar]
- 31.Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, et al. Interleukin-6 stimulates lipolysis and fat oxidation in humans. Journal of Clinical Endocrinology and Metabolism. 2003;88:3005–3010. doi: 10.1210/jc.2002-021687. [DOI] [PubMed] [Google Scholar]
- 32.Sopasakis VR, Sandqvist M, Gustafson B, Hammarstedt A, Schmelz M, et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obesity Research. 2004;12:454–460. doi: 10.1038/oby.2004.51. [DOI] [PubMed] [Google Scholar]
- 33.Agraval N, Chitrika A, Bhattacharjee J, Jain SK. Correlations of tumor necrosis factor-αand interleukin-6 with anthropometric indices of obesity and parameters of insulin resistance in healthy north Indian population. JIACM. 2011;13:196–204. [Google Scholar]
- 34.Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–2135. doi: 10.1001/jama.282.22.2131. [DOI] [PubMed] [Google Scholar]
- 35.Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. Journal of the American Medical Association. 2006;295:1412–1419. doi: 10.1001/jama.295.12.1412. [DOI] [PubMed] [Google Scholar]
- 36.Lemieux I, Pascot A, Prud’homme D, Alméras N, Bogaty P. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:961–967. doi: 10.1161/01.atv.21.6.961. [DOI] [PubMed] [Google Scholar]
- 37.Noronha JA, Medeiros CC, Cardoso Ada S, Gonzaga NC, Ramos AT, et al. C-reactive protein and its relation to high blood pressure in overweight or obese children and adolescents Rev. Paul Pediatr. 2013;31(3):331–7. doi: 10.1590/S0103-05822013000300009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Hak AE, Stehouwer CDA, Bots ML, Polderman KH, Schalkwijk CG, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:1986–1991. doi: 10.1161/01.atv.19.8.1986. [DOI] [PubMed] [Google Scholar]
- 39.Anderson JW, Konz EC, Jenkins DJA. Health advantages and disadvantages of weight-reducing diets: a computer analysis and critical review. Journal of the American College of Nutrition. 2001;19:578–590. doi: 10.1080/07315724.2000.10718955. [DOI] [PubMed] [Google Scholar]
- 40.Yamaguchi N, Takahashi T, Sakuma M, Sugita T, Uchikawa K, et al. Acupuncture regulates leukocyte subpopulations in human peripheral blood. Evid Based Complement Alternat Med. 2007;4:447–453. doi: 10.1093/ecam/nel107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Yim YK, Lee H, Hong KE, Kim YI, Lee BR, et al. Electro-acupuncture at acupoint ST36 reduces inflammation and regulates immune activity in collagen-induced arthritic mice. Evid Based Complement Alternat Med. 2007;4:51–57. doi: 10.1093/ecam/nel054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Tian L, Huang YX, Tian M, Gao W, Chang Q. Downregulation of electroacupuncture at ST36 on TNF-alpha in rats with ulcerative colitis. World J Gastroenterol. 2003;9:1028–1033. doi: 10.3748/wjg.v9.i5.1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Jong MS, Hwang SJ, Chen FP. Effects of electro-acupuncture on serum cytokine level and peripheral blood lymphocyte subpopulation at immune-related and non-immune-related points. Acupunct Electrother Res. 2006;31:45–59. doi: 10.3727/036012906815844337. [DOI] [PubMed] [Google Scholar]
- 44.Saliha Karatay, Fatih Akcay, Kadir Yildirim, Fazile Hatipoglu Erdem, Filiz Alp. Effects of Some Acupoints (Du-14, Li-11, St-36, and Sp-6) on Serum TNF-αand hsCRP Levels in Healthy Young Subjects. J Altern Complement Med. 2011;17:347–350. doi: 10.1089/acm.2009.0461. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Petti FB, Liguori A, Ippoliti F. Study on cytokines IL-2, IL-6, IL-10 in patients of chronic allergic rhinitis treated with acupuncture. Journal of Traditional Chinese Medicine. 2002;22:104–111. [PubMed] [Google Scholar]
- 46.Dagenais NJ, Jamali F. Protective effects of angiotensin II interruption: evidence for anti-inflammatory actions. Pharmacother. 2005;13:1213–1229. doi: 10.1592/phco.2005.25.9.1213. [DOI] [PubMed] [Google Scholar]
- 47.Casimiro L, Barnsley L, Brosseau L, et al. Acupuncture and electroacupuncture for the treatment of rheumatoid arthritis. Cochrane Database of Systematic Reviews. 2005:4. doi: 10.1002/14651858.CD003788.pub2. Article ID CD003788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Zanette SDA, Born IG, Brenol JCT, Xavier RM. A pilot study of acupuncture as adjunctive treatment of rheumatoid arthritis. Clinical Rheumatology. 2008;27:627–635. doi: 10.1007/s10067-007-0759-y. [DOI] [PubMed] [Google Scholar]
- 49.Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. Diabetes Research and Clinical Practice. 2005;69:29–35. doi: 10.1016/j.diabres.2004.11.007. [DOI] [PubMed] [Google Scholar]